Hepatitis B carriage explains the excess rate of hepatocellular carcinoma for Maori, Pacific Island and Asian people compared to Europeans in New Zealand

International Journal of Epidemiology

Volumn 28, Issue 2, 1999, Pages 204-210

  Blakely, Tony A ^a,c   Bates, Michael N ^a   Baker, Michael G ^a   Tobias, Martin ^b  

^a INSTITUTE OF ENVIRONMENTAL SCIENCE AND RESEARCH   (New Zealand)

^b MINISTRY OF HEALTH   (New Zealand)

^c UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Chronic hepatitis B; Ethnic groups; Hepatitis B; Hepatitis B surface antigens; Hepatocellular carcinoma; New Zealand; Population attributable risk

Indexed keywords

HEPATITIS B SURFACE ANTIGEN;

COMPARATIVE STUDY; ETHNICITY; HEPATITIS; RISK FACTOR;

ADOLESCENT; ADULT; AGED; ARTICLE; ASIAN; CANCER REGISTRY; CHILD; DISEASE CARRIER; ETHNIC GROUP; ETHNOLOGY; FEMALE; HEPATITIS B; HUMAN; INCIDENCE; INFANT; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; NEW ZEALAND; NORMAL HUMAN; PREVALENCE; PRIORITY JOURNAL; RISK;

EID: 0032943623     PISSN: 03005771     EISSN: None     Source Type: Journal    
DOI: 10.1093/ije/28.2.204     Document Type: Article

References (28)

1. Pearce N, Newell KW, Carter H. Incidence of hepatocellular carcinoma in New Zealand, 1974-78: ethnic, sex, and geographic differences. NZ Med J 1985;98:1033-36.
2. Tukuitonga CF, Solomon N. Incidence of cancer among Pacific Island people in New Zealand. NZ Med J 1992;105:463-66.
3. Simmons GC, Yeong M-L. Lee SP. The association of hepatitis B viral infection and hepatocellular infection in New Zealand. NZ Med J 1983;96:669-71.
4. Rothman K. Modern Epidemiology. Boston: Little, Brown and Company, 1986.
5. Beasley RP. Hepatitis B virus: the major etiology of hepatocellular carcinoma. Cancer 1988;61:1942-56.
6. North Health. Immunisation Coverage in North Health. Auckland: North Health, 1997.
7. Fraser J, Auld JJ. New Zealand. In: Parkin DM et al. (eds). Cancer Incidence in Five Continents. Lyon: International Agency for Research on Cancer, 1992.
8. Percy C, Van Holten V, Muir C. International Classification of Diseases for Oncology: ICD-O. Second Edn. Geneva: World Health Organization, 1990.
9. Tobias MI, Miller JA, Clements CJ, Patel AC. Hepatitis B in New Zealand children: the 1985 national immunisation survey. NZ Med J 1987;100:203-06.
10. Blakely T, Salmond C, Tobias M. Hepatitis B virus carrier prevalence in New Zealand: Population estimates using the 1987 police and customs survey. NZ Med J 1998;111:142-44.
11. Caselmann WH, Alt M. Hepatitis C virus infection as a major risk factor for hepatocellular carcinoma. J Hepatol 1996;24(Suppl.2):61-66.
12. Hwang S-J, Tong MJ, Lai PPC et al. Evaluation of hepatitis B and C viral markers: clinical significance in Asian and Caucasian patients with hepatocellular carcinoma in United States of America. J Gastroenterol Hepatol 1996;11:949-54.
13. Tsai J-F, Jeng J-E, Ho M-S, Chang W-Y, Lin Z-Y, Tsai J-H. Hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Chinese: a case-control study. Int J Cancer 1994;56:619-21.
14. Stroffolini T, Chiaramonte M, Tirbelli C et al. Hepatitis C virus infection, HBsAg carrier state and hepatocellular carcinoma: relative risk and population attributable risk from a case-control study in Italy. J Hepatol 1992;16:360-63.
15. Chen C-J, Liang K-Y, Chang A-S et al. Effects of hepatitis B virus, alcohol drinking, cigarette smoking and familial tendency on hepatocellular carcinoma. Hepatology 1991;13:398-406.
16. Tanaka K, Hirohata T, Takeshita S et al. Hepatitis B virus, cigarette smoking and alcohol consumption in the development of hepatocellular carcinoma: a case-control study in Fukuoka, Japan, Int J Cancer 1992;51:500-14.
17. Milne A, Allwood GK, Moyes CD, Pearce NE, Lucas CR. Prevalence of hepatitis B infections in a multiracial New Zealand Community. NZ Med J 1985;98:529-32.
18. Bortolotti F. Chronic hepatitis B acquired in childhood: unanswered questions and evolving issues. J Hepatol 1994;21:904-09.
19. Coursaget P, Le Cann P, Leboulleux D, Diop M-T, Bao O, Coll A-M. Detection of hepatitis B virus DNA by polymerase chain reaction in HBsAg negative Sengalese patients suffering from cirrhosis or primary liver cancer. Microbiol Letters 1991;83:35-38.
20. Brechot C, Degos F, Lugassy C et al. Hepatitis B virus in patients with chronic liver disease and negative tests for hepatitis B surface antigen. N Engl J Med 1985;312:270-76.
21. Paterlini P, Gerken G, Nakajima E et al. Polymerase chain reaction to detect hepatitis B virus DNA and RNA sequences in primary liver cancers from patients negative for hepatitis B surface antigen. N Engl J Med 1990;323:80-85.
22. Pomare E, Keefe-Ormsby V, Ormsby C et al. Hauora: Maori Standards of Health III. Wellington: Eru Pomare Maori Health Research Centre, 1995.
23. McMahon BJ, Rhoades ER, Heyward WL et al. A comprehensive program to reduce the incidence of hepatitis B virus infection and its sequelae in Alaskan natives, Lancet 1987;2:1134-36.
24. Tang Z-Y, Yu Y-Q, Zhou X-D et al. Surgery of small hepatocellular carcinoma: analysis of 144 cases. Cancer 1989;64:536-41.
25. Mima S, Sekiya C, Kanagawa H et al. Mass screening for hepato-cellular carcinoma: experience in Hokkaido, Japan. J Gastroenterol Hepatol 1994;9:361-65.
26. Sherman M, Peltekian K, Lee C. Screening for hepatocellular carcinoma in chronic carriers of hepatitis B virus: incidence and prevalence of hepatocellular carcinoma in a North American urban population. Hepatology 1995;22:432-38.
27. London W, Chen G-C, Shen F-M, Zhou T, Evans A. Early detection of hepatocellular carcinoma in China and United States. Abstract. In: Proceedings of the Hepatitis Workshop. Whakatane: Hepatitis Foundation, 1993.
28. Lee C-L, Ko Y-C. Hepatitis B vaccination and hepatocellular carcinoma in Taiwan. Pediatrics 1997;99:351-53.